Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Astellas Pharma Global Development, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

A Study to Assess the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Mycophenolate Mofetil in Healthy Adult Subjects

Phase 1

Completed

Conditions: Healthy Subjects
Pharmacokinetics of Isavuconazole
Pharmacokinetics of Plasma Mycophenolic Acid (MPA)
Pharmacokinetics of Plasma Phenolic Glucuronide of MPA (MPAG)

Interventions: Drug: isavuconazole
Drug: Mycophenolate mofetil

First Posted Date: 2012-10-22

Last Posted Date: 2012-10-22

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 24

Registration Number: NCT01711489

Locations: 🇺🇸
Parexel International, LLC, Glendale, California, United States

A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Prednisone in Healthy Adult Subjects

Phase 1

Completed

Conditions: Healthy Subjects
Pharmacokinetics of Isavuconazole
Pharmacokinetics of Prednisolone

Interventions: Drug: Isavuconazole
Drug: Prednisone

First Posted Date: 2012-10-22

Last Posted Date: 2012-10-22

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 21

Registration Number: NCT01711827

Locations: 🇺🇸
Parexel International, LLC, Glendale, California, United States

A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies

Phase 1

Terminated

Conditions: Pharmacokinetics of ASP9853
Non-hematologic Malignancies

Interventions: Drug: ASP9853
Drug: Docetaxel
Drug: Paclitaxel

First Posted Date: 2012-10-12

Last Posted Date: 2024-11-07

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 21

Registration Number: NCT01705483

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Barbara Ann Karmanos Cancer Center, Detroit, Michigan, United States

and more 1 locations

A Phase I Study to Compare 3 Different Strengths of an Extended Release Formulation of ASP015K to an Immediate Release Formulation of ASP015K

Phase 1

Completed

Conditions: Pharmacokinetics of ASP015K
Healthy Volunteers
Food Effect

Interventions: Drug: ASP015K ER
Drug: ASP015K IR

First Posted Date: 2012-09-17

Last Posted Date: 2015-09-01

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 30

Registration Number: NCT01686217

Locations: 🇺🇸
Parexel International, Baltimore, Maryland, United States

Study of the Pharmacokinetics of ASP1941 and the Effect on Glucose Concentrations in Male and Female Young and Elderly Healthy Adults

Phase 1

Completed

Conditions: Healthy Volunteers
Pharmacokinetics of ASP1941

Interventions: Drug: ASP1941
Drug: Placebo

First Posted Date: 2012-09-05

Last Posted Date: 2012-09-05

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 65

Registration Number: NCT01678287

Locations: 🇺🇸
Comprehensive Phase One, Miramar, Florida, United States

Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric Cancer

Phase 1

Completed

Conditions: CLDN18.2-positive Gastric Adenocarcinoma
CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction
CLDN18.2-positive Adenocarcinoma of Esophagus

Interventions: Drug: IMAB362
Drug: Zoledronic acid
Drug: Interleukin-2 (3 million IU)
Drug: Interleukin-2 (1 million IU)

First Posted Date: 2012-08-24

Last Posted Date: 2024-11-14

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 29

Registration Number: NCT01671774

Locations: 🇩🇪
Institut für Klinische Forschung, Krankenhaus Nordwest GmbH, Frankfurt, Hessen, Germany
🇩🇪
BAG / Onkologische Schwerpunktpraxis, Dresden, Sachsen, Germany
🇩🇪
Charité Universitätsmedizin Berlin - CVK, Med. Klinik m.S. Hämatologie und Onkologie, Berlin, Germany

and more 6 locations

A Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 2

Withdrawn

Conditions: Metastatic Castration-Resistant Prostate Cancer

Interventions: Drug: Enzalutamide

First Posted Date: 2012-08-13

Last Posted Date: 2012-09-17

Lead Sponsor: Astellas Pharma Global Development, Inc.

Registration Number: NCT01663415

Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole

Phase 1

Completed

Conditions: Healthy Volunteers
Pharmacokinetics of Isavuconazole
Pharmacokinetics of Lopinavir/Ritonavir

Interventions: Drug: Isavuconazole
Drug: Lopinavir/ritonavir

First Posted Date: 2012-08-08

Last Posted Date: 2015-02-23

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 68

Registration Number: NCT01660477

Locations: 🇺🇸
Parexel International, Glendale, California, United States

Drug Interaction Study of Isavuconazole and Warfarin in Healthy Male Subjects

Phase 1

Completed

Conditions: Pharmacokinetics of Isavuconazole
Pharmacokinetics of S- and R-warfarin
Pharmacodynamics of Warfarin
Healthy Volunteers

Interventions: Drug: Isavuconazole
Drug: Warfarin

First Posted Date: 2012-08-06

Last Posted Date: 2012-08-28

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 20

Registration Number: NCT01657825

Locations: 🇺🇸
Spaulding Clinical, West Bend, Wisconsin, United States

Drug Interaction Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose of Isavuconazole in Healthy Adult Subjects

Phase 1

Completed

Conditions: Healthy Adult Volunteers
Pharmacokinetics of Isavuconazole
Pharmacokinetics of Ketoconazole

Interventions: Drug: Isavuconazole
Drug: Ketoconazole

First Posted Date: 2012-08-06

Last Posted Date: 2015-09-01

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 24

Registration Number: NCT01657838

Locations: 🇺🇸
Spaulding Clinical, West Bend, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy